Skip to main content

CorWave Presented First Successful In Vivo 60-Day Study on Its Innovative LVAD Cardiac Support Device

By September 11, 2019October 24th, 2024Healthcare

CorWave Presented First Successful In Vivo 60-Day Study on Its Innovative LVAD Cardiac Support Device

https://www.corwave.com/wp-content/uploads/2019/09/20190911_CorWave_PR_EN_ESAO-chronic-preclinical-trial-60d.pdf

Tags:

M&L GROUP

We are a family investment firm that cultivates pioneering ventures into successful enterprises with passion, energy and integrity.

Hospitality
Healthcare
Shipping
Alternatives
Media room
About
Contact

Copyright © 2025 M&L Group. All Rights Reserved. | Legal.

Branding and website design by Stepworks